Cargando…

Programmed death-ligand 1 expression by digital image analysis advances thyroid cancer diagnosis among encapsulated follicular lesions

Recognition of noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) that distinguishes them from invasive malignant encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC) can prevent overtreatment of NIFTP patients. We and others have previously repo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsieh, Anne M.-Y., Polyakova, Olena, Fu, Guodong, Chazen, Ronald S., MacMillan, Christina, Witterick, Ian J., Ralhan, Ranju, Walfish, Paul G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929424/ https://www.ncbi.nlm.nih.gov/pubmed/29731981 http://dx.doi.org/10.18632/oncotarget.24833

Ejemplares similares

Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features
por: Fu, Guodong, et al.
Publicado: (2017)

Diagnostic Value of Galectin-3 in Distinguishing Invasive Encapsulated Carcinoma from Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features (NIFTP)†
por: Fu, Guodong, et al.
Publicado: (2021)

Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants
por: Chowdhury, Subrata, et al.
Publicado: (2016)

Development of a Molecular Assay for Detection and Quantification of the BRAF Variation in Residual Tissue From Thyroid Nodule Fine-Needle Aspiration Biopsy Specimens
por: Fu, Guodong, et al.
Publicado: (2021)

ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy
por: Fu, Guodong, et al.
Publicado: (2016)

Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma
por: Kunavisarut, Tada, et al.
Publicado: (2012)

Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis
por: Somasundaram, Raj Thani, et al.
Publicado: (2016)

EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
por: Ralhan, Ranju, et al.
Publicado: (2010)

Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules
por: Fu, Guodong, et al.
Publicado: (2023)

Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness
por: So, Anthony K.-C., et al.
Publicado: (2012)

Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in “Low Risk” Prostate Adenocarcinomas
por: Assi, Jasmeet, et al.
Publicado: (2015)

An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid Carcinoma
por: He, Helen C.-H., et al.
Publicado: (2012)

Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients
por: Kumar, Manish, et al.
Publicado: (2015)

Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy
por: Srivastava, Gunjan, et al.
Publicado: (2015)

Immunohistochemistry Helps to Distinguish Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features/Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma with Other Follicular Thyroid Lesions
por: Chuang, Hao-Wen, et al.
Publicado: (2021)

Transglutaminase 2 Overexpression in Tumor Stroma Identifies Invasive Ductal Carcinomas of Breast at High Risk of Recurrence
por: Assi, Jasmeet, et al.
Publicado: (2013)

Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients
por: Srivastava, Gunjan, et al.
Publicado: (2014)

Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers
por: Ralhan, Ranju, et al.
Publicado: (2010)

Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer
por: Chauhan, S S, et al.
Publicado: (2015)

Molecular Correlates and Nuclear Features of Encapsulated Follicular-Patterned Thyroid Neoplasms
por: Jung, Chan Kwon, et al.
Publicado: (2021)

Clinical Significance of Altered Expression of β-Catenin and E-Cadherin in Oral Dysplasia and Cancer: Potential Link with ALCAM Expression
por: Kaur, Jatinder, et al.
Publicado: (2013)

Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis
por: Hasan, Raghibul, et al.
Publicado: (2014)

Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours
por: Sheu, S-Y, et al.
Publicado: (2010)

Challenge in the Pathological Diagnosis of the Follicular-Patterned Thyroid Lesions
por: Elsers, Dalia A, et al.
Publicado: (2021)

Slug Is a Predictor of Poor Prognosis in Esophageal Squamous Cell Carcinoma Patients
por: Hasan, Md. Raghibul, et al.
Publicado: (2013)

Management of thyroid nodules with indeterminate fine-needle aspiration cytology: histogram analysis of greyscale sonograms and molecular assay of residual tissue from fine-needle aspiration biopsies
por: Fu, Guodong, et al.
Publicado: (2022)

Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma
por: Matta, Ajay, et al.
Publicado: (2009)

Metastatic brain lesion as the initial presentation of follicular thyroid carcinoma
por: Alanazi, Abdulaziz, et al.
Publicado: (2022)

Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features
por: Jeon, Min Ji, et al.
Publicado: (2016)

Classification of Thyroid Follicular Lesions Based on Nuclear Texture Features—Lesion Size Matters
por: Metze, Konradin, et al.
Publicado: (2010)

Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model
por: Hasan, Raghibul, et al.
Publicado: (2022)

Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer
por: Kumar, Manish, et al.
Publicado: (2015)

Fine-needle aspiration of follicular lesions of the thyroid. Diagnosis and follow-Up
por: Deveci, M Salih, et al.
Publicado: (2006)

Computerized nuclear morphometry in the diagnosis of thyroid lesions with predominant follicular pattern
por: Aiad, HA, et al.
Publicado: (2009)

Diagnosis and Reporting of Follicular-Patterned Thyroid Lesions by Fine Needle Aspiration
por: Faquin, William C.
Publicado: (2009)

Follicular thyroid lesions: is there a discriminatory potential in the computerized nuclear analysis?
por: Valentim, Flávia O, et al.
Publicado: (2018)

Malignancy Rate in Thyroid Nodules with Atypia or Follicular Lesion of Undetermined Significance
por: Pasha, Hamdan Ahmed, et al.
Publicado: (2020)

Molecular Characterization of Thyroid Follicular Lesions in the Era of “Next-Generation” Techniques
por: Rossi, Esther Diana, et al.
Publicado: (2022)

Brain metastasis from thyroid adenomatous nodules or an encapsulated thyroid follicular tumor without capsular and vascular invasion: a case report
por: Terada, Tadashi
Publicado: (2009)

An encapsulated oncoytic neoplasm of follicular origin of thyroid, expressing neuroendocrine markers. A case report and literature review
por: Filotico, Marcello, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oq16v1vhr0hia05ep7jdr7lh0f